Aller au contenu principal
Accès ouvert déclaré 2025 article

1406 Predictors of Post-COVID Clinical and Cognitive Consequences: An Update

0Citations signalées — pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Abstract Introduction “Post-acute sequelae of SARS-COV-2 infection (PASC)” is a condition with a wide range of physical and mental health consequences that are present four or more weeks after SARS-COV-2 infection. Fatigue is one of the common post-COVID conditions, but whether sleep disturbances due to COVID-19 infection influence the chronic physical and mental health consequences are unknown. The goal of this pilot study is to assess if sleep disturbances and sleep apnea severity contribute to PASC. Methods We prospectively collected sleep, quality of life (QoL) and neurocognitive data in patients with PASC and control participants with OSA but without past COVID-19 infection. Questionnaires were administered at baseline and after 3 months to evaluate sleepiness, fatigue, sleep disturbance, and QoL. Cognitive testing included Trail Making Test (TMT) A and B, Paced Auditory Serial Addition Test (PASAT), Stroop Task, Digit Coding, Hopkins Verbal Learning Test-R (HVLT-R), Weschler Abbreviated Scale Intelligence II (WASI), Weschler Memory Scale IV (WMS), and Psychomotor Vigilance Test (PVT), respectively. COVID-infection related data was also collected. Results We have enrolled 104 total participants thus far; 47 patients with PASC (39 males, 8 females; age: 60.0±12.9 years, BMI: 31.6±5.6 kg/m2, AHI: 36.6±27.8 events/hr, Education: 14.5±2.1 years) and 57 controls (48 males, 9 females; age: 64.6±11.9 years, BMI: 32.1±8.5 kg/m2, AHI: 41.4±27.5 events/hr, Education: 14.3±2.6 years). Baseline data in PASC vs. controls are given as: FSS Total Score: 39.0±13.4 vs. 33.4±14.9.4(p=0.06), ESS: 10.4±4.6 vs.9.0±5.5, PROMISE Sleep Impairment Score: 22.6±9.3 vs.18.7±8.3 (p< 0.05), 6-Minute Walk Test Total Distance Walked: 467.7±102.5 vs. 420.4±84.4 meters, FOSQ Total Score: 16.1±3.0 vs. 15.8±3.9, TMT-A 93.6±16.5 vs. 105.0±14.8 (p< 0.01), TMT-B: 92.9±21.1 vs. 101.6±17.8 (p=0.07), HVLTR Total Recall: 82.8±17.3 vs. 86.6±15.7, WMSIV Visual Reproduction Delayed Recall: 99.0±18.2 vs. 103.8±18.7, Stroop Color-Word Score: 92.0±15.5 vs. 94.8±13.2, WASI-II FISQ4 Score: 93.9±14.9 vs. 94.5±14.8, PASAT Rate 2 Correct: 31.8±24.1% vs. 34.4±14.8%, PVT Mean Reaction Time: 392.9±376.4 vs. 346.7±245.9 ms, PVT lapses 9.5±26.7 vs 1.5±3.2. Conclusion Sleep impairment, reduced attention span and increased lapses in vigilance were noted in patients with PASC vs controls. Additional analyses will delineate the associations between post-COVID symptoms, sleep disturbances and cognitive consequences following SARS-CoV-2 infection. Support (if any) VHA RR&D # RX004396

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
1406 Predictors of Post-COVID Clinical and Cognitive Consequences: An Update
Date Crossref
01/05/2025
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Long-Term Effects of COVID-19

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.